Formulation of chrysin loaded nanostructured lipid carriers using Box Behnken design, its characterization and antibacterial evaluation alone and in presence of probiotics co-loaded in gel

[1]  Y. Choonara,et al.  Polysaccharide, fecal microbiota, and curcumin-based novel oral colon-targeted solid self-nanoemulsifying delivery system: formulation, characterization, and in-vitro anticancer evaluation , 2022, Materials Today Chemistry.

[2]  H. Dureja,et al.  Multivariate Data Analysis and Central Composite Design-Oriented Optimization of Solid Carriers for Formulation of Curcumin-Loaded Solid SNEDDS: Dissolution and Bioavailability Assessment , 2022, Pharmaceutics.

[3]  S. Madhunapantula,et al.  Quality by Design Based Formulation of Xanthohumol Loaded Solid Lipid Nanoparticles with Improved Bioavailability and Anticancer Effect against PC-3 Cells , 2022, Pharmaceutics.

[4]  D. Chellappan,et al.  Novel Nanostructured Lipid Carriers Co-Loaded with Mesalamine and Curcumin: Formulation, Optimization and In Vitro Evaluation , 2022, Pharmaceutical Research.

[5]  K. Dua,et al.  Topical non-aqueous nanoemulsion of Alpinia galanga extract for effective treatment in psoriasis: in vitro and in vivo evaluation. , 2022, International journal of pharmaceutics.

[6]  R. Alduina,et al.  Lipid Nanocarriers-Loaded Nanocomposite as a Suitable Platform to Release Antibacterial and Antioxidant Agents for Immediate Dental Implant Placement Restorative Treatment , 2021, Pharmaceutics.

[7]  R. Tyagi,et al.  Nanostructured Lipid Carrier–Mediated Transdermal Delivery of Aceclofenac Hydrogel Present an Effective Therapeutic Approach for Inflammatory Diseases , 2021, Frontiers in Pharmacology.

[8]  N. Ahmad,et al.  Lipid-based nanoparticles for psoriasis treatment: a review on conventional treatments, recent works, and future prospects , 2021, RSC advances.

[9]  Sanjaykumar B. Bari,et al.  Development of ritonavir-loaded nanostructured lipid carriers employing quality by design (QbD) as a tool: characterizations, permeability, and bioavailability studies , 2021, Drug Delivery and Translational Research.

[10]  J. Simal-Gándara,et al.  An updated review on the versatile role of chrysin in neurological diseases: Chemistry, pharmacology, and drug delivery approaches. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[11]  Gautam Singhvi,et al.  Design and dermatokinetic evaluation of Apremilast loaded nanostructured lipid carriers embedded gel for topical delivery: A potential approach for improved permeation and prolong skin deposition. , 2021, Colloids and surfaces. B, Biointerfaces.

[12]  S. Grabbe,et al.  Psoriasis: Embarking a dynamic shift in the skin microbiota , 2021, Journal of cosmetic dermatology.

[13]  Adejumoke Lara Ajiboye,et al.  Olanzapine Loaded Nanostructured Lipid Carriers via High Shear Homogenization and Ultrasonication , 2021, Scientia Pharmaceutica.

[14]  M. Koland,et al.  Topical Delivery of Apremilast Loaded Nanostructured Lipid Carrier Based Hydrogel for Psoriasis Therapy , 2021 .

[15]  M. Apostolou,et al.  The Effects of Solid and Liquid Lipids on the Physicochemical Properties of Nanostructured Lipid Carriers. , 2021, Journal of pharmaceutical sciences.

[16]  Wei Zhang,et al.  Skin and Gut Microbiome in Psoriasis: Gaining Insight Into the Pathophysiology of It and Finding Novel Therapeutic Strategies , 2020, Frontiers in Microbiology.

[17]  Bhupinder Singh,et al.  QbD-steered development of Biotin-Conjugated Nanostructured Lipid Carriers for Oral Delivery of Chrysin: Role of Surface Modification for Improving Biopharmaceutical Performance. , 2020, Colloids and surfaces. B, Biointerfaces.

[18]  Ajazuddin,et al.  Statistically optimized calcipotriol fused nanostructured lipid carriers for effectual topical treatment of psoriasis , 2020 .

[19]  Mayur M. Patel,et al.  Fabrication, optimisation and in vitro evaluation of docetaxel and curcumin Co-loaded nanostructured lipid carriers for improved antitumor activity against non-small cell lung carcinoma , 2020, Journal of microencapsulation.

[20]  D. Hsu,et al.  Role of skin and gut microbiota in the pathogenesis of psoriasis, an inflammatory skin disease , 2020, Medicine in Microecology.

[21]  Z. Siddik,et al.  Optimization of nanostructured lipid carriers: understanding the types, designs, and parameters in the process of formulations , 2020, Journal of Nanoparticle Research.

[22]  G. Kulkarni,et al.  Topical delivery of Tacrolimus using liposome containing gel: An emerging and synergistic approach in management of psoriasis. , 2020, Medical hypotheses.

[23]  S. Joshi,et al.  Bioavailability enhancement of repaglinide from transdermally applied nanostructured lipid carrier gel: Optimization, in vitro and in vivo studies , 2020, Journal of Drug Delivery Science and Technology.

[24]  P. Puranik,et al.  Analytical Method Development, Characterization, Evaluation of In-vitro Antioxidant and Anticancer Activity of Flavone Chrysin in HeLa Cells , 2020, International Journal of Pharmaceutical Sciences and Drug Research.

[25]  Nan-Lin Wu,et al.  Chrysin alleviates imiquimod-induced psoriasis-like skin inflammation and reduces the release of CCL20 and antimicrobial peptides , 2020, Scientific Reports.

[26]  M. Yasir,et al.  Nanostructured Lipid Carriers: A Groundbreaking Approach for Transdermal Drug Delivery , 2020, Advanced pharmaceutical bulletin.

[27]  M. Shariati,et al.  Chrysin: Pharmacological and therapeutic properties. , 2019, Life sciences.

[28]  I. Nikolić,et al.  Tacrolimus-loaded lecithin-based nanostructured lipid carrier and nanoemulsion with propylene glycol monocaprylate as a liquid lipid: formulation characterization and assessment of dermal delivery compared to referent ointment. , 2019, International journal of pharmaceutics.

[29]  H. Yang,et al.  Formulation And Evaluation Of Nanostructured Lipid Carriers (NLCs) Of 20(S)-Protopanaxadiol (PPD) By Box-Behnken Design , 2019, International journal of nanomedicine.

[30]  Annu,et al.  Optimization of Nanostructured Lipid Carriers of Lurasidone Hydrochloride Using Box-Behnken Design for Brain Targeting: In Vitro and In Vivo Studies. , 2019, Journal of pharmaceutical sciences.

[31]  Abhishek Shah,et al.  Colloidal nanostructured lipid carriers of pentoxifylline produced by microwave irradiation ameliorates imiquimod-induced psoriasis in mice. , 2019, Colloids and surfaces. B, Biointerfaces.

[32]  Sung-Joo Hwang,et al.  The Delivery Strategy of Paclitaxel Nanostructured Lipid Carrier Coated with Platelet Membrane , 2019, Cancers.

[33]  A. L. Ruela,et al.  Development and characterization of nanostructured lipid carrier-based gels for the transdermal delivery of donepezil. , 2019, Colloids and surfaces. B, Biointerfaces.

[34]  Jiyong Liu,et al.  Transdermal drug delivery of triptolide‐loaded nanostructured lipid carriers: Preparation, pharmacokinetic, and evaluation for rheumatoid arthritis , 2019, International journal of pharmaceutics.

[35]  Ki‐Hyun Kim,et al.  Improvement of antihyperglycemic activity of nano-thymoquinone in rat model of type-2 diabetes. , 2018, Chemico-biological interactions.

[36]  J. Musakhanian,et al.  Skin Penetration and Permeation Properties of Transcutol®—Neat or Diluted Mixtures , 2018, AAPS PharmSciTech.

[37]  M. Khalid,et al.  A Naturally Occurring Flavone (Chrysin): Chemistry, Occurrence, Pharmacokinetic, Toxicity, Molecular Targets and Medicinal Properties , 2018, Journal of Biologically Active Products from Nature.

[38]  Y. Huh,et al.  Probiotic Lactobacillus sakei proBio-65 Extract Ameliorates the Severity of Imiquimod Induced Psoriasis-Like Skin Inflammation in a Mouse Model , 2018, Front. Microbiol..

[39]  Sanyog Jain,et al.  Coenzyme Q10 and retinaldehyde co-loaded nanostructured lipid carriers for efficacy evaluation in wrinkles , 2017, Journal of drug targeting.

[40]  R. Salehi,et al.  Chrysin loaded nanostructured lipid carriers (NLCs) triggers apoptosis in MCF-7 cancer cells by inhibiting the Nrf2 pathway , 2017 .

[41]  A. Mahmoud,et al.  Nanostructured lipid carriers as semisolid topical delivery formulations for diflucortolone valerate , 2017, Journal of liposome research.

[42]  J. Schalkwijk,et al.  The skin microbiota , 2016 .

[43]  Chieh-Shan Wu,et al.  Lactobacillus pentosus GMNL-77 inhibits skin lesions in imiquimod-induced psoriasis-like mice , 2016, Journal of food and drug analysis.

[44]  C. Fiorica,et al.  A facile way to build up branched high functional polyaminoacids with tunable physicochemical and biological properties , 2016 .

[45]  S. Baboota,et al.  Nanostructured lipid carrier system for topical delivery of terbinafine hydrochloride , 2015 .

[46]  Harish Padh,et al.  Application of quality by design approach for intranasal delivery of rivastigmine loaded solid lipid nanoparticles: Effect on formulation and characterization parameters. , 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[47]  S. Eğrilmez,et al.  Preparation and in vitro-in vivo evaluation of ofloxacin loaded ophthalmic nano structured lipid carriers modified with chitosan oligosaccharide lactate for the treatment of bacterial keratitis. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[48]  A. Nayak,et al.  Carbopol gel containing chitosan-egg albumin nanoparticles for transdermal aceclofenac delivery. , 2014, Colloids and surfaces. B, Biointerfaces.

[49]  T. Dinan,et al.  Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut , 2013, Gut microbes.

[50]  R. Tan,et al.  Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables. , 2011, Colloids and surfaces. B, Biointerfaces.

[51]  K. Srinivasan,et al.  Investigation of preparation parameters of nanosuspension by top-down media milling to improve the dissolution of poorly water-soluble glyburide. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[52]  G. Kulkarni,et al.  Optimization of formulation and process variable of nanosuspension: An industrial perspective. , 2010, International journal of pharmaceutics.

[53]  Prasanta Chowdhury,et al.  Kinetic modeling on drug release from controlled drug delivery systems. , 2010, Acta poloniae pharmaceutica.

[54]  Youmie Park,et al.  High-performance liquid chromatographic analysis of chrysin derivatives on a Nova-Pak® C18 column , 2002, Archives of pharmacal research.

[55]  Ibrahim El-Gibaly,et al.  Oral delayed-release system based on Zn-pectinate gel (ZPG) microparticles as an alternative carrier to calcium pectinate beads for colonic drug delivery. , 2002, International journal of pharmaceutics.

[56]  Laxmidhar Sahoo.  Nanostructured Lipid Carrier (NLC) -A Promising Drug Delivery for Transdermal Application , 2020 .

[57]  V. Patravale,et al.  Fabrication of Nanostructured Lipid Carriers (NLC)-Based Gels from Microemulsion Template for Delivery Through Skin. , 2019, Methods in molecular biology.

[58]  R. Gupta,et al.  Formulation and in-vitro drug Released Mechanism of CNS Acting Venlafaxine Nanostructured Lipid Carrier for Major Depressive Disorder , 2018 .

[59]  V. Natesan,et al.  Chrysin: Sources, beneficial pharmacological activities, and molecular mechanism of action. , 2018, Phytochemistry.

[60]  E. Ghazy,et al.  NEBIVOLOL HYDROCHLORIDE LOADED NANOSTRUCTURED LIPID CARRIERS AS TRANSDERMAL DELIVERY SYSTEM:-PART 2:- HYDROGEL PREPARATION, EVALUATION AND PERMEATION STUDY , 2016 .

[61]  R. Hüttenrauch,et al.  [Dependence of the release of active principles from ointment bases upon the degree of order of the solid phase]. , 1979, Die Pharmazie.